Found 0 matching trials
Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors PHASE1 This is an open-label, multicenter, Phase Ib, dose-escalation study designe...
Show More Location
California Pacific Med Center
Learn More & Join Trial
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) PHASE1 The purpose of this study will be to evaluate the safety, tolerability, and...
Show More Location
University of Alabama At Birmingham Comprehensive Cancer Center
Learn More & Join Trial
Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy NA As cytotoxic agents, DTX and PTX have a narrow therapeutic window. BSA dosi...
Show More Location
Sun Yat-Sen University Cancer Center
Learn More & Join Trial
Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma PHASE3 In this study, the investigators aim to compare the progression-free surviv...
Show More Learn More & Join Trial
Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC) PHASE3 To compare the efficacy and safety in subjects with advanced or metastatic ...
Show More Location
Mayo Clinic Arizona
Learn More & Join Trial
Amrubicin (AMR) Trial in Patients With Non-small Cell Lung Cancer PHASE3 The study is to evaluate the effect of amrubicin (AMR) compared to docetaxe...
Show More Learn More & Join Trial
Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial PHASE3 This is an open-label, multicenter, 2x2 factorial design, randomized contro...
Show More Location
Klinikum der Universität München, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Campus Innenstadt
Learn More & Join Trial
4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF PHASE3 Taxane-based adjuvant chemotherapy is standard in node-positive (N+) early ...
Show More Location
Ev. Hospital Bethesda
Learn More & Join Trial
Studying the Benefits of Adjuvant Sequential vs. Combined Taxane Based Chemotherapy, Followed by Different Biological Treatment Strategies in Early, HER2-positive Breast Cancer PHASE3 This is an open-label, multicenter randomized controlled, Phase III study c...
Show More Location
Frauenklinik der Universität München Campus Innenstadt
Learn More & Join Trial
Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen PHASE4 This is a prospective, Phase IV, multi-center, single arm, open-label, inte...
Show More Learn More & Join Trial